INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Why Open API Architecture Matters In Clinical Research

  Clinical trials need flexible workflows, but layered integrations add complexity. Open APIs enable real-time data exchange so processes adapt without fragile dependencies or added overhead.

• Automated Evidence Generation For Regulatory-Grade RWD

  Global regulatory agencies increasingly adopt Real-World Evidence, demanding higher data quality and automated AI-driven platforms to meet evolving standards and improve drug development pathways.

• The Digital Teammate: How AI Is Changing Clinical Research

  AI in clinical research serves as a "digital colleague," enhancing workflows, accelerating data analysis, and empowering study teams with precision, and insightful solutions for better patient outcomes.

• Harnessing AI for Pre-Award Landscape Analysis And Site Selection

  AI-driven insights transform site selection and feasibility, enabling faster decisions and reducing risk. Predictive modeling and real-time data improve pre-award planning and trial outcomes.

• Patient-Focused Data Capture For Cancer Research

  8/21/2025

  In a field where innovation is constant and patient experience is pivotal, oncology demands eCOA solutions designed to balance scientific rigor with human realities.

• Castor eConsent: Site View

  8/21/2025

  Study coordinators aim to enroll participants efficiently through a partnership that leverages direct-to-patient marketing to streamline recruitment.

• The Future Of Patient Recruitment: Leveraging RWD For Precision

  4/25/2025

  To combat the costly challenges of patient recruitment and keep trials on track, sponsors can leverage real-world data.

• CNS Trials With Sensors To Capture Patient Data

  9/16/2025

  Learn how sensor data and digital endpoints can address challenges in central nervous system (CNS) clinical trials.

• The FDA's Remote Regulatory Assessments: The Future Of Inspections

  1/31/2025

  Remote Regulatory Assessments (RRAs) provide distinct advantages over traditional inspections, such as increased efficiency, reduced travel costs, and enhanced global oversight capabilities.